T2 Biosystems raises $15 million Series C round

May 25, 2010 by MassDevice staff

T2 Biosystems Inc. raises $15 million in a Series C funding round to bring its benchtop MRI-based diagnostic device to market.

T2 Biosystems logo

T2 Biosystems Inc. raised about $15 million in a Series C funding round it plans to use to bring its benchtop MRI-based diagnostic device to market.

The Cambridge, Mass.-based firm said Physic Ventures led the round, along with new backers Arcus Ventures, RA Capital, Camros Capital, WS Investments and existing investors Flagship Ventures, Polaris Venture Partners, Flybridge Capital Partners and Partners Healthcare.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp